A Study Evaluating Venetoclax in Combination With Low-Dose Cytarabine in Treatment-Naïve Participants With Acute Myelogenous Leukemia
Conditions
- Acute Myelogenous Leukemia
- AML
Interventions
- DRUG: Venetoclax
- DRUG: Cytarabine
Sponsor
AbbVie
Collaborators